News & Analysis on Clinical Trial Services & Contract Research And Development
An enzyme-based process operated by Lonza for the production of the major chiral building block for Pfizer's Lipitor, the world's best selling drug, has won its designer Codexis a top green chemistry award for its high yield, speed, efficiency and...
Wyeth has announced that it has selected NovaScreen to conduct a high-throughput screening (HTS) campaign, which makes use of Caliper's microfluidic screening platform, which utilises reproducible electrophoretic separation of assay components
In the face of generic competition, Abbott has asked Irish biotechnology firm Elan to use its NanoCrystal technology to develop an "all in one" oral dose formulation combining two cholesterol drugs, AstraZeneca's Crestor and Abbott's Tricor, as...
SR Pharma has recruited Genzyme, BioSpring and OctoPlus to formulate and manufacture its lead RNAi therapeutic product Atu027 to good manufacturing practice (GMP) standards, as its liposomal drug delivry system moves forward.
Although patent expirations are set to increase the size of the generic drug market, the impact of greater scrutiny from healthcare policymakers means that generic manufacturers may make more drugs but not necessarily more money.
Technology firm Symyx has acquired Autodose, a maker of precision powder-dispensing equipment, as it seeks to develop the next generation of high-throughput benchtop automation systems.
A cancer biology discovery could lead to new diabetes treatments after it was discovered that a mutation in a tumour suppressor gene causes pancreatic islet cells to reproduce.
Isotechnika has received an additional US patent for its lead immunosuppressive drug, which is the first patent to be issued in this patent family in the US. The lead compound has demonstrated encouraging results in recent Phase II tests.